Geode Capital Management, LLC Scynexis Inc Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
A detailed history of Geode Capital Management, LLC transactions in Scynexis Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 418,465 shares of SCYX stock, worth $326,402. This represents 0.0% of its overall portfolio holdings.
Number of Shares
418,465
Previous 419,488
0.24%
Holding current value
$326,402
Previous $398,000
29.65%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding SCYX
# of Institutions
46Shares Held
11.8MCall Options Held
0Put Options Held
0-
Federated Hermes, Inc. Pittsburgh, PA2.9MShares$2.26 Million0.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$1.74 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$1.29 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.23MShares$958,5490.22% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$433,3320.7% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $25.5M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...